RT Journal Article SR Electronic T1 Fast and accurate diagnostics from highly multiplexed sequencing assays JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.05.13.20100131 DO 10.1101/2020.05.13.20100131 A1 Booeshaghi, A. Sina A1 Lubock, Nathan B. A1 Cooper, Aaron R. A1 Simpkins, Scott W. A1 Bloom, Joshua S. A1 Gehring, Jase A1 Luebbert, Laura A1 Kosuri, Sri A1 Pachter, Lior YR 2020 UL http://medrxiv.org/content/early/2020/05/16/2020.05.13.20100131.abstract AB Scalable, inexpensive, accurate, and secure testing for SARS-CoV-2 infection is crucial for control of the novel coronavirus pandemic. Recently developed highly multiplexed sequencing assays that rely on high-throughput sequencing (HMSAs) can, in principle, meet these demands, and present promising alternatives to currently used RT-qPCR-based tests. However, the analysis and interpretation of HMSAs requires overcoming several computational and statistical challenges. Using recently acquired experimental data, we present and validate an accurate and fast computational testing workflow based on kallisto and bustools, that utilize robust statistical methods and fast, memory efficient algorithms for processing high-throughput sequencing data. We show that our workflow is effective at processing data from all recently proposed SARS-CoV-2 sequencing based diagnostic tests, and is generally applicable to any diagnostic HMSAs.Competing Interest StatementASB, JG, LL, and LP declare no conflicts of interest. SK, NLB, ARC, SWS and JSB are employees of Ocant, which developed SwabSeq. SwabSeq is released under the terms of the Octant Covid License.Funding StatementNone.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data, code and methods used to generate the results in this manuscript are open source freely available. All code to reproduce every figure and analysis for this manuscript is located here: https://github.com/pachterlab/BLCSBGLKP_2020. Each notebook can be run directly on Google Colab by pressing "Open in Colab" → "Runtime" → "Run all". The links to all FASTQ files can be found in Supplementary Table 1. The SwabSeq protocol is described at https://www.notion.so/Octant-SwabSeq-Testing-9eb80e793d7e46348038aa80a5a901fd. Software programs used are listed in Supplementary Table 2. https://github.com/pachterlab/BLCSBGLKP_2020